ACA

Acorn Capital Advisors Portfolio holdings

AUM $153M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$150M
AUM Growth
-$35.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
22
New
Increased
Reduced
Closed

Top Buys

1
+$1.65M
2
+$1.45M
3
+$1.2M
4
TRVI icon
Trevi Therapeutics
TRVI
+$904K
5
VYNE icon
VYNE Therapeutics
VYNE
+$520K

Top Sells

1
+$20.6K
2
+$13.7K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
1
CG Oncology
CGON
$3.19B
$27.7M 18.49%
1,131,501
URGN icon
2
UroGen Pharma
URGN
$954M
$16.8M 11.18%
1,516,303
YMAB
3
DELISTED
Y-mAbs Therapeutics
YMAB
$14.3M 9.56%
3,235,387
+373,562
TRVI icon
4
Trevi Therapeutics
TRVI
$1.3B
$13.5M 9%
2,144,844
+143,796
CADL icon
5
Candel Therapeutics
CADL
$287M
$12.2M 8.11%
2,152,252
+212,608
PBYI icon
6
Puma Biotechnology
PBYI
$254M
$11.7M 7.78%
3,940,052
BCAX
7
Bicara Therapeutics
BCAX
$873M
$8.38M 5.59%
643,382
+1
TARA icon
8
Protara Therapeutics
TARA
$198M
$5.45M 3.64%
1,279,800
TERN icon
9
Terns Pharmaceuticals
TERN
$1.23B
$5.44M 3.63%
1,971,264
OKUR
10
OnKure Therapeutics
OKUR
$44.2M
$5.12M 3.42%
1,439,674
VSTM icon
11
Verastem
VSTM
$609M
$4.7M 3.13%
779,498
CYBN
12
Cybin
CYBN
$186M
$4.66M 3.11%
734,394
+1
CRDF icon
13
Cardiff Oncology
CRDF
$154M
$4.53M 3.02%
1,442,308
OPTN
14
DELISTED
OptiNose
OPTN
$3.88M 2.59%
422,814
+1
WHWK
15
Whitehawk Therapeutics
WHWK
$105M
$2.03M 1.35%
1,139,363
-7,689
XFOR icon
16
X4 Pharmaceuticals
XFOR
$324M
$1.75M 1.17%
243,688
MURA icon
17
Mural Oncology
MURA
$36.2M
$1.6M 1.07%
1,269,715
-16,364
AURA icon
18
Aura Biosciences
AURA
$375M
$1.45M 0.97%
+590,508
BCAB icon
19
BioAtla
BCAB
$39M
$1.41M 0.94%
4,032,046
QTTB icon
20
Q32 Bio
QTTB
$31.3M
$1.33M 0.88%
803,425
VYNE icon
21
VYNE Therapeutics
VYNE
$8.82M
$1.24M 0.83%
785,938
+328,968
ACRV icon
22
Acrivon Therapeutics
ACRV
$73.3M
$823K 0.55%
405,237